WALTER LUC

APH president Walter Luc sells 365.1K shares for $49.2M at $134.65 (50.8% of holdings)

Walter Luc, President of Amphenol's HES Division, executed two separate sales on 2025-10-24 totaling 365,118 shares for $49,163,430.79 at $134.65 per share, reducing his holdings from 718,860 shares to 353,742 shares (a -50.8% reduction). The current stock price of $135.91 is at the 52-week high, and the stock has advanced 10.9% over the past 30 days and 29.1% over 90 days. However, his prior trades at Amphenol show a pattern of poor timing: all 5 previous sales resulted in positive 90-day returns (ranging from +8.3% to +37.6%), meaning he consistently sold before subsequent rallies rather than before declines. The company's fundamentals remain solid with FY revenue growth of +21.2% and a P/E of 43.56, suggesting sustained operational momentum. The magnitude of this sale (over $49M) and the 50% reduction in personal holdings warrant attention given the equity market context, though the stock's position at 52-week highs and the insider's historical pattern of selling into strength rather than strength into weakness should temper any negative interpretation.

Amphenol President Walter Luc sells 286,000 APH shares ($26.1M) at $91.43; stock at 52-week high with prior APH sells poorly timed.

Walter Luc, President of the HES Division, sold 286,000 shares (286.0K shares) of Amphenol at $91.43 on 2025-06-03, reducing his holdings by 38.8% from 737,790 to 451,790 shares. The sale occurred as the stock traded at $91.68 current price, at the top of the 52-week range ($58.39–$91.68), following a 41.7% 90-day appreciation. However, his prior trades at Amphenol present a concerning pattern: of five prior transactions at this ticker, only 1 of 3 measurable sales proved well-timed (negative 90d return), while two recent April 2025 sales have shown +12.7% 30-day returns, and a May 2024 sale was dramatically poorly timed with a -49.3% 30-day outcome that reversed into a -50.5% 90-day loss. His cross-ticker track record shows a 60.0% well-timed rate across 7 prior sells with an average 90-day return of -27.6%, but the same-ticker history at Amphenol (with only 33% timing accuracy on measurable outcomes) suggests less precision at this company. This sale at a cyclical peak warrants attention to whether forward guidance remains robust enough to justify the valuation.

Walter Luc sells 390,000 APH shares at $75.91 for $29.6M, reducing holdings 46.3%

Walter Luc, President of the HES Division, executed two separate sales totaling 390,000 shares (390.0K shares) for $29,605,797.00 ($29.6M) on 2025-04-25, at a blended average price of $75.91. This represents a -46.3% reduction in his pre-transaction holdings (from 841,790 to 451,790 shares). The current stock price of $76.68 is just -2.4% from the 52-week high, and the stock has appreciated +15.2% over the past 30 days and +10.5% over 90 days—periods spanning after this sale. Examining his prior trades at APH specifically, Luc's prior five sales show mixed timing: two sales in July 2024 posted positive 30d and 90d returns (poorly-timed), while three sales (including two in May 2024 and one in July 2023) yielded negative 90-day returns (-49.1%, -49.3%, -50.6%), indicating those were well-timed ahead of subsequent declines. The substantial size of this current transaction and the 46.3% portfolio reduction merit monitoring for any material developments at the division or company level.

Amphenol President Walter Luc sells 276,000 shares for $17.7M across two transactions, reducing holdings by 38.1%

Walter Luc (President, HES Division) executed 2 separate sales totaling 276,000 shares for $17,700,821.80 (blended average $64.13) on 2024-07-26 and 2024-07-29, reducing his stake from 723,790 shares to 447,790 shares (a 38.1% reduction). The current price of $61.94 is now 12.0% below the 52-week high of $70.41 and 8.1% lower over the past 30 days, placing the execution within a recently declining market. Luc's cross-ticker track record shows 3 prior sells with an average 90-day return of -54.1% and a 90% well-timed rate, indicating his prior sales have consistently preceded stock declines. At the same ticker (APH), his prior 2024 sales on 2024-05-23 and 2024-05-22 showed 30-day declines of -49.3% and -49.1%, respectively, and his 2023-07-28 sale showed a 90-day decline of -54.1%—a pattern of sales before sustained downward moves. The stock's -0.5% annual revenue growth and elevated P/E of 35.39 suggest a valuation-intensive context where insider liquidation of this magnitude warrants investor attention.